SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...
Throughout the last three months, 4 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the ...
Procept BioRobotics Corporation (NASDAQ:PRCT) is one of the best up and coming stocks to buy according to Wall Street. On December 18, Truist analyst Richard Newitter lowered the firm’s price target ...
PROCEPT BioRobotics PRCT is gearing up to announce its quarterly earnings on Wednesday, 2025-08-06. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
Full-year 2025 revenue guidance was updated to approximately $323 million, reflecting 44% growth compared to 2024. This includes US system revenue of $95 million, driven by greenfield sales and some ...
4 analysts have expressed a variety of opinions on PROCEPT BioRobotics (NASDAQ:PRCT) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...
Hosted on MSN
PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires
We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands ...
With an estimated 40 million men in the U.S. living with benign prostatic hyperplasia, or BPH, Procept Biorobotics has developed a treatment device that certainly holds water. Literally: The AquaBeam ...
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
"We began 2025 with strong performance, delivering total revenue growth of 55% in the first quarter. Procedural momentum remained robust heading into the second quarter, reinforcing our confidence ...
On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics (NASDAQ:PRCT), raising concerns about the claims surrounding its market potential and growth prospects, suggesting ...
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics today announced the appointment of Kevin Waters as chief financial officer. Mr. Waters brings approximately 20 years of finance and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results